Tissue Regeneration Therapeutics Inc.
Tissue Regeneration Therapeutics (TRT) develops our patented Human Umbilical Cord PeriVascular Cell (HUCPVC) technology platform, to provide licensing opportunities to collaborating partners.
Together we create cell and regenerative strategies that maximize the utility of publicly sourced tissue – for therapies that address important health care issues of today.
Together, we build very powerful biology.
NEWS! - Tissue Regeneration Therapeutics Grants Exclusive U.S. License for PeriVascular Umbilical Cord Stem Cell Technology to PerkinElmer's ViaCord® Cord Blood Banking Business. click here for more information.
Together we create cell and regenerative strategies that maximize the utility of publicly sourced tissue – for therapies that address important health care issues of today.
Together, we build very powerful biology.
NEWS! - Tissue Regeneration Therapeutics Grants Exclusive U.S. License for PeriVascular Umbilical Cord Stem Cell Technology to PerkinElmer's ViaCord® Cord Blood Banking Business. click here for more information.